Emma R. Job

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells.

Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells.

Journal: PloS one

Published: October 14, 2021

Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase.

Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase.

Journal: NPJ vaccines

Published: September 10, 2021

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.

Journal: mBio

Published: July 13, 2021

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies.

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies.

Journal: mBio

Published: October 24, 2019

Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs.

Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs.

Journal: NPJ vaccines

Published: April 06, 2018

Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.

Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.

Journal: Journal of virology

Published: September 07, 2017

Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus.

Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 23, 2017

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.

Journal: Journal of visualized experiments : JoVE

Published: May 19, 2017

Neutralizing inhibitors in the airways of naïve ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses.

Neutralizing inhibitors in the airways of naïve ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses.

Journal: Virology

Published: December 16, 2015

Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection.

Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection.

Journal: PloS one

Published: May 13, 2015

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.

Journal: PloS one

Published: December 15, 2014

Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.

Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.

Journal: Viruses

Published: December 23, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026